Pharming (PHAR) Total Debt (QoQ) (2021 - 2026)
Pharming (PHAR) Total Debt (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.72% |
| Dec 31, 2025 | -0.45% |
| Sep 30, 2025 | 2.05% |
| Jun 30, 2025 | 8.85% |
| Mar 31, 2025 | 1,875.24% |
| Dec 31, 2024 | 103.15% |
| Sep 30, 2024 | -254.52% |
| Jun 30, 2024 | -35.26% |
| Mar 31, 2024 | 7,295.23% |
| Dec 31, 2023 | -98.59% |
| Sep 30, 2023 | -3.32% |
| Jun 30, 2023 | 0.45% |
| Mar 31, 2023 | 7,455.20% |
| Dec 31, 2022 | 572.23% |
| Sep 30, 2022 | -99.80% |
| Jun 30, 2022 | -5.41% |
| Mar 31, 2022 | 44,228.93% |
| Dec 31, 2021 | -99.78% |
| Sep 30, 2021 | -2.94% |
| Jun 30, 2021 | 44,006.50% |